Dr. Richardson on the Mechanism of Action of CC-92480 in Multiple Myeloma OncLive 1:52 4 years ago 292 Далее Скачать
Dr. Richardson on the Next Steps With CC-92480 Research in Relapsed/Refractory Multiple Myeloma OncLive 1:00 4 years ago 57 Далее Скачать
Dr. Richardson on First-In-Human Phase 1 Trial With CC-92480 in R/R Myeloma OncLive 1:36 4 years ago 90 Далее Скачать
CC-92480: a novel CELMoD, in R/R myeloma VJHemOnc – Video Journal of Hematology & HemOnc 6:32 4 years ago 343 Далее Скачать
Preliminary data on mezigdomide plus dexamethasone and bortezomib in R/R multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 2:41 2 years ago 191 Далее Скачать
Current and Future Directions for Novel Therapy for Multiple Myeloma: Paul G. Richardson, MD Dana-Farber Cancer Institute 37:46 2 years ago 1 957 Далее Скачать
Evaluating Response Rates With CC-92480 Combination in Multiple Myeloma Targeted Oncology 1:42 4 years ago 85 Далее Скачать
First-in-human phase I study of the novel CELMoD agent CC-92480 combined with dex in pts with RRMM International Myeloma Foundation 11:06 4 years ago 896 Далее Скачать
Dr. Richardson Discusses New Directions in Multiple Myeloma OncLive 1:36 5 years ago 211 Далее Скачать
What are myeloma targets? #myeloma HealthTree University for Multiple Myeloma 11:35 2 years ago 312 Далее Скачать
CC-92480 (mezigdomide) in R/R MM VJHemOnc – Video Journal of Hematology & HemOnc 1:02 4 years ago 43 Далее Скачать
Relapsed Multiple Myeloma: Iberdomide and CC-480 CELMoDs Multiple Myeloma Today 2:54 2 years ago 113 Далее Скачать
Paul Richardson, MD Shares a Review of the IMW Boston Conference - IMW 2019 HealthTree Foundation for Multiple Myeloma 7:32 5 years ago 394 Далее Скачать
The importance of tailored treatment approach in multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 5:33 4 years ago 125 Далее Скачать
The safety & efficacy of mezigdomide plus dexamethasone and bortezomib or carfilzomib in R/R myeloma VJHemOnc – Video Journal of Hematology & HemOnc 3:50 2 years ago 219 Далее Скачать
New Options To Treat Newly Dx, Relapsed Myeloma — Dr. Paul Richardson | MCRT Webcast July 11 HealthTree Foundation for Multiple Myeloma 11:37 4 years ago 166 Далее Скачать
What is a CELMoD? How is it different from and IMiD? #myeloma HealthTree University for Multiple Myeloma 5:43 2 years ago 3 158 Далее Скачать
The Evolving Role of Immune Therapies in Multiple Myeloma International Myeloma Foundation 29:01 3 years ago 971 Далее Скачать
Should we use melflufen to treat relapsed patients with poor prognosis? Multiple Myeloma Hub 6:34 3 years ago 664 Далее Скачать
Dr. Paul G. Richardson Provides Study Updates on the Phase 3 DETERMINATION Trial for NDMM patients International Myeloma Foundation 17:24 2 years ago 1 543 Далее Скачать
